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Background The congenital cardiac catheterization project on outcomes (C3PO) was established to develop outcome assessment methods for 
pediatric catheterization.
Methods Eight pediatric centers recorded demographic, procedural, and adverse events (AE) categorized by severity (level 1 to 5) on all cases 
using a web-based data entry tool. Two samples were independently audited for validity and completeness. Consensus and empiric methods were 
used to develop 4 procedure type risk categories. Indicators of hemodynamic vulnerability and threshold values were determined empirically. 
Univariate analysis identified factors associated with AE level 3, 4, and 5 between 8/07 and 12/08. A multivariable logistic model based on this AE 
outcome was created; factors significant at p<0.05 were retained in the final model. The final model was then validated in a prospectively collected 
data set between 1/09 and 12/09. Discrimination was assessed by the c-statistic and calibration by the Hosmer-Lemeshow test. The final model 
was used to calculate standardized adverse event ratios (SAER) by institution.
Results Between 8/07 and 12/10, 9362 cases were recorded, with AE level 3, 4, or 5 in 454 cases (5%). Empiric analysis yielded 4 independent 
indicators of hemodynamic vulnerability: CI < 2.8 L/min/M2, systemic ventricle end-diastolic pressure ≥ 18 mmHg, systemic arterial saturation < 
95% or <78% if single ventricle physiology, and PA pressure systolic ≥ 45mmHg or mean ≥ 17 mmHg if single ventricle. The final multivariable model 
included procedure type risk category (odds ratios for category 2=2.4, 3=5.3, 4=7.4, all p<0.001) and number of hemodynamic indicators (odds 
ratio 1=1.8, 2+=2.5, p<0.001), c-statistic 0.737 and Hosmer-Lemeshow test p=0.98. Models performed well in the validation data set, c-statistic 
0.737and Hosmer-Lemeshow test p=0.39. For all institutions in 2008 and 2009 SAER ranged from 0.60 to 1.55 and all 95% confidence intervals 
included 1.0, indicating no performance outliers.
Conclusions This method to adjust for case mix complexity allows equitable comparisons of AE outcomes among institutions performing 
catheterization procedures for congenital heart disease.
